background
sever
acut
respiratori
syndrom
coronaviru
broke
wuhan
hubei
china
studi
sought
elucid
novel
predictor
diseas
sever
patient
coronaviru
case
hospit
wuhan
china
clinic
featur
chronic
comorbid
demograph
data
laboratori
radiolog
data
review
outcom
patient
sever
pneumonia
nonsever
pneumonia
compar
use
statist
packag
social
scienc
ibm
corp
armonk
ny
usa
explor
clinic
characterist
risk
factor
receiv
oper
characterist
curv
use
screen
optim
predictor
risk
factor
predict
power
verifi
intern
valid
total
patient
diagnos
enrol
studi
includ
sever
pneumonia
nonsever
pneumonia
independ
risk
factor
sever
pneumonia
age
odd
ratio
confid
interv
ci
p
nl
ci
p
crp
ci
p
ddimer
ci
p
identifi
product
nl
crp
ddimer
import
predict
valu
sever
cutoff
valu
neg
predict
valu
less
nl
crp
ddimer
posit
predict
valu
test
set
sensit
specif
train
set
neg
posit
predict
valu
respect
specif
sensit
conclus
product
nl
crp
ddimer
may
import
predictor
diseas
sever
patient
sinc
last
decemb
grow
cluster
pneumonia
case
caus
novel
coronaviru
report
wuhan
hubei
provinc
china
viru
rapidli
spread
wuhan
surround
provinc
citi
attract
worldwid
attent
public
panic
eventu
pneumonia
design
coronaviru
world
health
organ
februari
intern
committe
taxonomi
virus
declar
viru
offici
classifi
sever
acut
respiratori
syndrom
sar
coronaviru
day
belong
genu
beta
coronaviru
coronavirida
famili
includ
deadli
sar
middl
east
respiratori
syndrom
coronavirus
studi
shown
display
roughli
homolog
bat
homolog
human
sarscov
highli
contagi
high
mortal
rate
diseas
prone
caus
respiratori
symptom
high
fever
dyspnea
cough
may
rapidli
develop
sever
pneumonia
acut
respiratori
distress
syndrom
ard
multipl
organ
dysfunct
syndrom
death
number
patient
increas
number
sever
case
thu
far
drug
approv
verifi
specif
viru
thu
treatment
patient
critic
ill
becom
one
main
challeng
face
clinician
need
adopt
reliabl
predictor
sever
identifi
treat
sever
patient
earli
stage
studi
therefor
sought
explor
adopt
factor
predict
sever
patient
provid
evid
use
screen
sever
ill
patient
patient
enrol
studi
hospit
central
hospit
wuhan
tertiari
teach
hospit
respons
treatment
patient
assign
chines
govern
patient
local
resid
wuhan
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
contact
peopl
confirm
suspect
contract
ill
relev
laboratori
examin
common
pathogen
detect
chest
comput
tomographi
ct
scan
complet
patient
also
underw
nucleic
acid
swab
test
patient
test
posit
other
test
neg
immatur
method
incorrect
sampl
method
use
nucleic
acid
detect
may
contribut
falseneg
result
highresolut
ct
scan
scan
layer
thick
mm
reconstruct
thick
layer
recommend
radiolog
examin
includ
patient
clinic
diagnos
accord
interim
guidanc
patient
suspect
ill
two
senior
respiratori
doctor
made
diagnosi
togeth
studi
particip
divid
two
group
patient
sever
pneumonia
nonsever
pneumonia
patient
follow
clinic
sign
consid
sever
pneumonia
fever
suspect
respiratori
infect
plu
either
respiratori
rate
greater
breathsmin
sever
respiratori
distress
spo
less
room
air
patient
ard
sepsi
septic
shock
also
includ
patient
without
sever
sign
includ
nonsever
pneumonia
group
patient
viral
bacteri
fungal
infect
upon
admiss
miss
data
exclud
studi
approv
ethic
committe
wuhan
central
hospit
studi
retrospect
studi
involv
patient
privaci
inform
consent
exempt
chronic
comorbid
demograph
data
laboratori
examin
chest
ct
scan
review
use
electron
medic
record
data
white
blood
cell
wbc
count
lymphocyt
l
neutrophil
n
alanin
transaminas
alt
aspart
aminotransferas
ast
serum
albumin
alb
serum
creatinin
cr
blood
urea
nitrogen
bun
ddimer
creactiv
protein
crp
level
includ
data
acquir
physician
result
examin
first
day
admiss
data
check
anoth
research
ascertain
accuraci
patient
randomli
assign
fashion
undergo
train
holdout
test
set
predictor
train
train
group
optim
cutoff
valu
obtain
intern
valid
assess
valu
predict
sever
statist
perform
classifi
measur
calcul
sensit
specif
neg
posit
predict
valu
continu
variabl
either
present
mean
compar
use
ttest
normal
distribut
describ
use
median
mannwhitney
u
test
use
comparison
categor
variabl
present
count
compar
chisquar
test
fisher
exact
test
logist
regress
analysi
use
assess
risk
factor
sever
pneumonia
receiv
oper
characterist
roc
curv
use
filter
predictor
intern
valid
use
valid
predict
valu
predictor
twosid
valu
less
consid
statist
signific
use
statist
packag
social
scienc
version
ibm
corp
armonk
ny
usa
statist
analysi
januari
februari
total
patient
enrol
elig
particip
final
includ
analysi
among
patient
posit
nucleic
acid
test
result
patient
nonsever
pneumonia
patient
sever
basic
characterist
studi
popul
shown
tabl
patient
sever
pneumonia
tend
older
also
patient
chronic
comorbid
high
blood
pressur
hbp
type
diabet
mellitu
coronari
heart
diseas
chd
chronic
obstruct
pulmonari
diseas
account
larger
proport
popul
sever
pneumonia
group
rel
nonsever
pneumonia
patient
sever
pneumonia
significantli
high
serum
wbc
count
n
crp
cr
bun
ddimer
level
lower
albumin
lymphocyt
level
ratio
neutrophil
lymphocyt
nl
significantli
higher
patient
sever
pneumonia
addit
signific
differ
alt
ast
time
onset
admiss
appar
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
determin
independ
risk
factor
sever
pneumonia
perform
logist
regress
analysi
result
indic
adjust
confound
factor
gender
hbp
chd
cr
bun
alb
independ
risk
factor
sever
pneumonia
age
odd
ratio
confid
interv
ci
p
nl
ci
p
crp
ci
p
ddimer
ci
p
tabl
roc
curv
use
analyz
predict
valu
nl
crp
ddimer
determin
diseas
sever
patient
area
roc
curv
explor
predict
valu
nl
crp
ddimer
sever
also
conduct
intern
valid
patient
randomli
select
total
popul
test
set
rest
design
train
set
basic
characterist
patient
two
set
list
tabl
roc
curv
new
predictor
test
set
shown
figur
cutoff
point
deriv
auc
ci
specif
sensit
train
set
figur
cutoff
valu
optim
cutoff
valu
obtain
averag
cutoff
valu
origin
data
group
train
set
thu
patient
train
test
set
reclassifi
accord
result
patient
nl
crp
ddimer
result
less
classifi
patient
nonsever
pneumonia
predict
group
otherwis
classifi
patient
sever
pneumonia
seen
tabl
neg
predict
valu
diagnosi
nonsever
pneumonia
less
nl
crp
ddimer
ci
posit
predict
valu
diagnosi
sever
pneumonia
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
tabl
crosssect
studi
sought
investig
predict
factor
sever
found
age
nl
crp
ddimer
independ
risk
factor
sever
result
suggest
age
posit
correl
sever
result
also
confirm
research
probabl
resist
elder
viru
decreas
age
increas
basic
diseas
mani
factor
moreov
aggrav
basic
diseas
profil
elderli
patient
would
also
lead
deterior
face
sever
pneumonia
increas
nl
crp
may
relat
cytokin
storm
produc
seri
inflammatori
respons
caus
disord
peripher
wbc
immun
cell
lymphocyt
observ
decreas
lymphocyt
indic
coronaviru
consum
mani
immun
cell
inhibit
bodi
cellular
immun
function
damag
lymphocyt
might
contribut
exacerb
patient
even
caus
death
signific
increas
ddimer
progress
sever
pneumonia
also
observ
consist
result
wang
may
correl
damag
pulmonari
arteri
caus
viru
lead
signific
embol
extens
alveolar
termin
capillari
chang
eventu
contribut
increas
ddimer
although
nl
crp
ddimer
independ
risk
factor
sever
roc
curv
show
low
predict
valu
sever
infect
clinic
practic
high
neg
predict
valu
crucial
evalu
patient
sever
sinc
failur
detect
sever
patient
could
devast
consequ
individu
studi
suggest
product
nl
crp
ddimer
better
predict
perform
sever
rel
singl
biomark
predict
valu
nl
crp
ddimer
also
confirm
intern
valid
stage
observ
neg
predict
valu
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
nl
crp
ddimer
posit
predict
valu
specif
sensit
appear
repres
improv
predict
compar
clinic
variabl
gener
product
nl
crp
ddimer
new
predict
valu
sever
studi
valid
nl
crp
ddimer
cutoff
point
predict
clinician
pay
close
attent
indic
calcul
valu
identifi
sever
patient
earli
possibl
importantli
studi
limit
first
laboratori
test
method
may
everi
hospit
optim
cutoff
point
product
valu
may
vari
patient
includ
studi
product
nl
crp
ddimer
found
first
time
largerscal
data
random
trial
need
estim
whether
use
predictor
clinic
practic
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
patient
nl
crp
ddimer
result
less
reclassifi
nonsever
group
result
greater
equal
reclassifi
sever
group
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
